Bioxys

We're thrilled to rejoin the World Federation of Nuclear Medicine and Biology (WFNMB)! The Algerian Association of Nuclear Medicine is once again a proud member, ready to contribute to and benefit from the global nuclear medicine community. 

🎤 Dr. Slimane ZEGHDOUD, Médecin spécialiste en oncologie nucléaire dans les traitements thérapeutiques par radiothérapie interne vectorisée. HCM Symposium Hôpital Chahids Mahmoudi : « Lutetium-PSMA dans le cancer de la prostate métastatique : la révolution Theranostique pour les patients. » ➡ Inscription visiteur : https://lnkd.in/eM5XpAbc ℹ️ Programme conférence : https://lnkd.in/ewUKYJCp 📅 19 -20- 21 Décembre 2024 📍 Palais de la Culture Moufdi Zakaria, Alger #Hospitaliaexpo #Santé #Médecine #Innovation #Événement #Algérie #pharma

Prof. Dr. Akram Al-Ibraheem (Part 1) Chairman of Nuclear Medicine and PET/CT at Jordan's King Hussein Cancer Center (KHCC) President of the Jordanian Society of Nuclear Medicine President-Elect of the Asia Oceania Federation of Nuclear Medicine and Biology (AOFNMB) Akram Al-Ibraheem MD, FRCP, FEBNM, FANMB, FRCPE #AICONM24 #Algeria #NuclearMedicine

كلمات الافتتاح الرسمية الدكتور ع. غضبان، رئيس الجمعية الجزائرية للطب النووي (AANM) Official opening adresses Dr. I. Ghedbane, president of the Algerian Association of Nuclear Medicine (AANM) IMAD GHEDBANE #AICONM24 #Algiers #NuclearMedicine

**AICONM24: Detailed Program & Abstract Book Now Available!** Download the complete program and abstract book for the Algiers International Conference on Nuclear Medicine here: https://lnkd.in/ddKhd8Jr #AICONM24 #NuclearMedicine #Algiers #Conference

**AICONM24: Detailed Program & Abstract Book Now Available!** Download the complete program and abstract book for the Algiers International Conference on Nuclear Medicine here: https://lnkd.in/ddKhd8Jr #AICONM24 #NuclearMedicine #Algiers #Conference

Welcoming the Advanced Accelerator Applications Molecular Imaging team to Siemens Healthineers! 🙌🙌🙌 Through our combination, we are adding 13 new sites across Europe, making us the leading radiopharmacy network in both the U.S. and Europe. As you can see in the images, radiopharmacies are highly specialized facilities. They are vital for producing radiotracers used in PET scans and theranostics. With their short shelf life—just minutes to a few hours—it is essential to produce them close to where they are used. With our expanded network, we’re proud to better support patients and care teams across Europe, contributing to timely access to life-saving diagnostics and faster, more precise care. Learn more: https://lnkd.in/eDCnbKAx

https://aamn.dz/aiconm24/ Sous le Haut patronage du Ministre d’état ,Ministre de l’Energie et des Mines et des Énergies Renouvelables et du Ministre de la Santé. L’AAMN et le COMENA vous invitent à Algiers International Conference On Nuclear Medicine le 13 et 14 décembre 2024 à l’hôtel El Aurassi Alger. مؤتمر الجزائر الدولي للطب النووي Conférence internationale d'Alger sur la médecine nucléaire IMAD GHEDBANE Président de l’Association Algérienne de Médecine Nucléaire #AICONM24 #AANM #COMENA #IAEA

Transforming Liver Cancer Care with Yttrium-90 Microsphere Therapy Liver cancer treatment has entered a new era with the advent of Yttrium-90 (Y-90) microsphere therapy, a groundbreaking procedure that delivers targeted radiation directly to tumors. Also known as radioembolization, this advanced approach brings hope to patients with both primary and metastatic liver tumors, particularly in cases where surgery or transplantation may initially seem unattainable. This treatment represents a sophisticated blend of interventional radiology, precision imaging, and radiopharmaceutical technology. Y-90 resin or glass microspheres are delivered through the liver’s blood vessels, directly targeting the tumor site with highly localized radiation. By leveraging nuclear medicine’s capabilities, this approach ensures both personalized care and improved outcomes for patients. Key Benefits    •   High Radiation Precision: Y-90 microspheres release potent radiation directly into tumors, sparing surrounding healthy liver tissue and reducing systemic side effects.    •   Effective for Advanced Cases: This therapy proves effective for large tumors and those involving complex conditions like portal vein thrombosis or widespread metastases.    •   Reduced Complications: Compared to conventional treatments such as transarterial chemoembolization (TACE), Y-90 therapy results in fewer complications, including a reduced incidence of post-embolization syndrome.    •   A Bridge to Surgery or Transplantation: By shrinking tumors, Y-90 therapy makes previously inoperable cases eligible for surgical resection or transplantation, opening doors to potentially curative treatments.    •   Improves long-term survival rates and quality of life for patients with appropriate selection and follow-up care. Where Can You Access Y-90 Microsphere Therapy? As a leader in precision oncology, we provide this innovative therapy at seven centers located in Istanbul, Antalya, Gaziantep, and Izmir. Our multidisciplinary teams, equipped with state-of-the-art facilities, ensure comprehensive care tailored to each patient’s unique needs. If you or someone you know is navigating liver cancer, consult with your oncologist to explore whether Y-90 therapy is the right option. Together, we can pave the way for better outcomes and renewed hope. #LiverCancer #Yttrium90 #Radioembolization #TargetedTherapy #PrecisionMedicine #NuclearMedicine #OncologyInnovation #AdvancedCancerCare